Effects of enzymatic activation on the distribution of fluorescently tagged MMP-2 cleavable peptides in cancer cells and spheroids

Bioconjugate Chemistry

Volumn 23, Issue 6, 2012, Pages 1110-1118

  Yamamoto, Natsuho ^a   Bryce, Nicole S ^a   Metzler Nolte, Nils ^b   Hambley, Trevor W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; MASS SPECTROMETRY; TUMORS;

C-TERMINUS; CANCER CELLS; CANCER SPHEROID; CELL SPHEROIDS; CELLULARS; COUMARIN 343; MATRIX METALLOPROTEINASE (MMPS); N TERMINUS; PEPTIDE CLEAVAGES; SYNTHESISED;

PEPTIDES;

GELATINASE A;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CELL CULTURE; CONFOCAL MICROSCOPY; CULTURE MEDIUM; ENZYME ACTIVATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PEPTIDE SYNTHESIS; PROTEIN EXPRESSION; SPHEROID CELL;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; COUMARINS; ENZYME ACTIVATION; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MATRIX METALLOPROTEINASE 2; PEPTIDE FRAGMENTS; PEPTIDES; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84862676503     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200561n     Document Type: Article

References (27)

1. Krueger, A., Kates, R. E., and Edwards, D. R. (2010) Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition. Biochim. Biophys. Acta, Mol. Cell Res. 1803, 95-102.
2. Overall, C. M., and Kleifeld, O. (2006) Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227-239.
3. Cockett, M. I., Murphy, G., Birch, M. L., O'Connell, J. P., Crabbe, T., Millican, A. T., Hart, I. R., and Docherty, A. J. P. (1998) Matrix metalloproteinases and metastatic cancer. Biochem. Soc. Symp. 63, 295-313.
4. Kleiner, D. E., and Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43 (Suppl), S42-51.
5. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
6. Atkinson, J. M., Siller, C. S., and Gill, J. H. (2008) Tumour endoproteases: the cutting edge of cancer drug delivery? Br. J. Pharmacol. 153, 1344-1352.
7. Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., and Tsien, R. Y. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. U.S.A. 101, 17867-72.
8. Mansour Ahmed, M., Drevs, J., Esser, N., Hamada Farid, M., Badary Osama, A., Unger, C., Fichtner, I., and Kratz, F. (2003) A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Cancer Res. 63, 4062-6.
9. Kirin, S. I., Noor, F., Metzler-Nolte, N., and Mier, W. (2007) Manual solid-phase peptide synthesis of metallocene-peptide bioconjugates. J. Chem. Educ. 84, 108-111.
10. Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P. I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-8.
11. Tremblay, P., Beaudet, M. J., Tremblay, E., Rueda, N., Thomas, T., and Vallieres, L. (2011) Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. J. Pathol. 224, 222-33.
12. Sun, Y., Liu, M., Yang, B., Li, B., and Lu, J. (2008) Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 265, 1385-91.
13. Bryce, N. S., Clark, E. S., Leysath, J. L., Currie, J. D., Webb, D. J., and Weaver, A. M. (2005) Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biol. 15, 1276-85.
14. Ireton, R. C., Davis, M. A., van Hengel, J., Mariner, D. J., Barnes, K., Thoreson, M. A., Anastasiadis, P. Z., Matrisian, L., Bundy, L. M., Sealy, L., Gilbert, B., van Roy, F., and Reynolds, A. B. (2002) A novel role for p120 catenin in E-cadherin function. J. Cell Biol. 159, 465-476.
15. Bryce, N. S., Zhang, J. Z., Whan, R. M., Yamamoto, N., and Hambley, T. W. (2009) Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models. Chem. Commun. (Cambridge, U. K.), 2673-2675.
16. Turk, B. E., Huang, L. L., Piro, E. T., and Cantley, L. C. (2001) Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667.
17. Yamamoto, N., Danos, S., Bonnitcha, P. D., Failes, T. W., New, E. J., and Hambley, T. W. (2008) Cellular uptake and distribution of cobalt complexes of fluorescent ligands. J. Biol. Inorg. Chem. 13, 861-871.
18. Minchinton, A. I., and Tannock, I. F. (2006) Drug penetration in solid tumours. Nat. Rev. Cancer 6, 583-592.
19. Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., and Nielsen, L. K. (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol. Bioeng. 83, 173-180.
20. Kim, B. J., Hambley, T. W., and Bryce, N. S. (2011) Visualising the hypoxia selectivity of cobalt(III) prodrugs. Chem. Sci. 2, 2135-2142.
21. Furlan, D., Sahnane, N., Carnevali, I., Cerutti, R., Bertoni, F., Kwee, I., Uccella, S., Bertolini, V., Chiaravalli, A. M., and Capella, C. (2008) Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas. Hum. Pathol. 39, 1483-1494.
22. Luo, Y., He, D.-L., Ning, L., Shen, S.-L., Li, L., Li, X., Zhau Haiyen, E., and Chung Leland, W. K. (2006) Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro. BJU Int. 98, 1315-9.
23. Thomas, A. L., and Steward, W. P. (2000) Marimastat: the clinical development of a matrix metalloproteinase inhibitor. Expert Opin. Invest. Drugs 9, 2913-2922.
24. Scherer, R. L., VanSaun, M. N., McIntyre, J. O., and Matrisian, L. M. (2008) Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol. Imaging 7, 118-31.
25. Tedelind, S., Jordans, S., Resemann, H., Blum, G., Bogyo, M., Fuhrer, D., and Brix, K. (2011) Cathepsin B trafficking in thyroid carcinoma cells. Thyroid Res. 4 (Suppl 1), S2.
26. Bjoerklund, M., and Koivunen, E. (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta, Rev. Cancer 1755, 37-69.
27. McIntyre, J. O., Fingleton, B., Wells, K. S., Piston, D. W., Lynch, C. C., Gautam, S., and Matrisian, L. M. (2004) Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem. J. 377, 617-628.